Publications by authors named "Yasmina Modena"

Claim this Profile
P
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?
Milena Gusella, Felice Pasini, Barbara Corso, Laura Bertolaso, Giovanni De Rosa, Yasmina Modena

Pharmacol Res Perspect· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical features of seronegative, but CSF antibody-positive, anti-NMDA receptor encephalitis.
Mar Guasp, Yasmina Módena, Thaís Armangue, Josep Dalmau, Francesc Graus

Neurol Neuroimmunol Neuroinflamm· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral maintenance metronomic vinorelbine versus best supportive care in advanced non-small-cell lung cancer after platinum-based chemotherapy: The MA.NI.LA. multicenter, randomized, controlled, phase II trial.
Marco Platania, Felice Pasini, Luca Porcu, Mattia Boeri, Francesco Verderame, Yasmina Modena

Lung Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung cancer: correlations with pharmacokinetics and MDR1 polymorphisms.
Milena Gusella, Felice Pasini, Donatella Caruso, Carmen Barile, Yasmina Modena

Cancer Chemother Pharmacol· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Metronomic Vinorelbine (OMV) in elderly or pretreated patients with advanced non small cell lung cancer: outcome and pharmacokinetics in the real world.
Felice Pasini, Carmen Barile, Donatella Caruso, Yasmina Modena, Anna Paola Fraccon

Invest New Drugs· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies for advanced and metastatic adenocarcinoma of the gastroesophageal junction: is there something new?
Felice Pasini, Anna Paola Fraccon, Yasmina Modena, Maria Bencivenga, Simone Giacopuzzi

Gastric Cancer· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germ line polymorphisms as predictive markers for pre-surgical radiochemotherapy in locally advanced rectal cancer: a 5-year literature update and critical review.
Elisa Pezzolo, Yasmina Modena, Barbara Corso, Pietro Giusti, Milena Gusella

Eur J Clin Pharmacol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age affects pegylated liposomal doxorubicin elimination and tolerability in patients over 70 years old.
Milena Gusella, Antonio Bononi, Yasmina Modena, Laura Bertolaso, Paola Franceschetti

Cancer Chemother Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equilibrative nucleoside transporter 1 genotype, cytidine deaminase activity and age predict gemcitabine plasma clearance in patients with solid tumours.
Milena Gusella, Felice Pasini, Caterina Bolzonella, Silvia Meneghetti, Carmen Barile, Yasmina Modena

Br J Clin Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis